The SAGE meeting of 21-23 October 2014 took place in the EB room at the WHO headquarters in Geneva. Available on this site you will find meeting information and background reading materials as well as presentations made at the meeting. The conclusions and recommendations of SAGE meeting are published in the WHO Weekly Epidemiological Record in English and French within two months of each SAGE meeting.
Strategic Advisory Group of Experts on Immunization (SAGE) - October 2014
Related
Background documents and presentations
SAGE Yellow Book - October 2014
Session: Report from IVB director
Background documents
SAGE tracking record of recommendations and action points
2014 Update on the Regional Immunization Program of the Americas
WHO Media centre: Ebola situation assessment - 1 October 2014
Presentations
Global report including key updates and challenges from regions-P. Duclos
Update on the Ebola outbreak and experimental Ebola vaccines-D. Wood
Session: report from GAVI
Session: Reports from other Advisory Committees on Immunization
Background documents
Global Advisory Committee on Vaccine Safety, 11–12 June 2014
Report from the IPAC meeting 11-12 June 2014
IPAC Call to action on Immunization Supply Chain and Logistics
Executive summary IVIR-AC recommendations 17-19 September 2014 meeting
Presentations
Report of the Global Advisory Committee on Vaccine Safety (GACVS)-M. Wharton
Report of the Immunization Practices Advisory Committee (IPAC)-C. Morgan
Report of the Expert Committee on Biological Standardization (ECBS)-E. Griffiths
Session: GVAP progress report
Background documents
2014 Assessment Report of the Global Vaccine Action Plan
Summary of the 2014 Assessment Report of the Global Vaccine Action Plan
67th WHA Global vaccine action plan, Report by the Secretariat
WHO 67th WHA Global vaccine action plan, Summary of session
Presentations
The GVAP Secretariat Report 2014: Update on process, new indicators and dashboard-T. Cherian
Summary of GVAP implementation progress review and recommendations for corrective actions-N. Arora
Session: Japanese encephalitis vaccines
Background documents
Background document on Japanese Encephalitis Vaccines
Position paper on the use of Japanese Encephalitis vaccine
Presentations
Vaccines available against JE-A. Barrett
Review of the evidence: vaccine immunogenicity, effectiveness, and co- administration-S. Hills
Review of the evidence: vaccine safety and other evidence review-H. Meyer
Review of proposed recommendations on Japanese encephalitis vaccines-P. Tharmaphornpilas
Session: Meningococcal A conjugate vaccine impact and routine immunization schedule in infants and young children
Background documents
Meningococcal vaccines: WHO position paper, November 2011
WHO immunological basis for immunization Series: Module 15: Meningococcal Disease
Report from WHO Global Advisory Committee on Vaccine Safety, 11-12 June 2014
Please refer to pp. 329-331: "Meningococcal A conjugate vaccine during pregnancy"
Presentations
Session: Global polio eradication initiative
Background documents
9th Meeting of the SAGE Polio Working Group (July 2014):Conclusions and recommendations
OPV Cessation: Protocol for a global coordinated switch from trivalent OPV to bivalent OPV. Note: the latest version of the switch Guidelines for National Operational Plans and other supporting materials are available here
Independent monitoring board of the global polio eradication initiative, May 2014 report
mOPV2 stockpile policy for type 2 outbreak response in the post cessation phase.
Plan for tOPV campaigns immediately prior to tOPV to bOPV switch: draft risk assessment concept note
Presentations
Introduction: Issues for SAGE decisions and discussions-B. Aylward
Major decisions for the OPV2 withdrawal: the report from the Polio Working Group-P. Figueroa
Type 2 risk assessment and response strategy after OPV2 withdrawal-R. Sutter
Operationalizing IPV and bOPV introduction in priority countries-M. Zaffran
Session: Hepatitis E vaccine
Background documents
Recommendations of HEV Working Group on the use of hepatitis E vaccine
Hepatitis E Vaccine: Composition, Safety, Immunogenicity and Efficacy
Hepatitis E: epidemiology and disease burden
Cost-effectiveness background on Hepatitis E Aggarwal R.
Presentations
Hepatitis E: epidemiology and disease burden-E. Teshale
Composition, safety, efficacy and immunogenicity of the licensed hepatitis E vaccine-R. Aggarwal
Recommendations of SAGE Working Group the hepatitis E vaccine-N. Arora
Session: Vaccine hesitancy
Background documents
Report of the Working Group on vaccine hesitancy. Report provided to SAGE ahead of the October 2014 SAGE meeting
Revised report of the Working Group on vaccine hesitancy. The report was revised after the October 2014 SAGE meeting
Full report of annexes to the report on vaccine hesitancy
Systematic review of strategies to address vaccine hesitancy
Systematic Review of Vaccine Hesitancy (website)